The Tel Aviv-based group was listed on the London Stock Exchange last month and was part of a number of new cannabis companies listed in the UK
() has signed a second supply contract for its medical cannabis inhalation device VapePod.
Under a new contract, Polish cannabis cultivation group PharmaCann will supply medical cannabis cartridges based on Kanabo’s proprietary formulation for the VapePod device.
READ: Kanabo Up As It Signs First UK Distribution Agreement
Up to 36,000 cartridges per month will be filled and prepared at PharmaCann’s facility in North Macedonia under the new agreement, Kanabo said.
Tel Aviv-based Kanabo raised £ 6 million when it went public on the London Stock Exchange last month. This is part of a number of new cannabis companies listed in the UK including MGC Pharmaceuticals PLC () and ().
Avihu Tamir, CEO of Kanabo, said, “With the increased fundraiser from the IPO, we can accelerate preparations for cannabis drug delivery and build our CBD wellness business.”